These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Neurofibromatosis type 1: a survey of 195 patients]. Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578 [TBL] [Abstract][Full Text] [Related]
5. [Lisch nodule in neurofibromatosis type 1]. Abaloun Y; Ajhoun Y Pan Afr Med J; 2017; 27():218. PubMed ID: 28979620 [TBL] [Abstract][Full Text] [Related]
6. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis]. Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164 [TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 1 and hypertension in pediatrics: case report]. Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069 [TBL] [Abstract][Full Text] [Related]
8. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1? Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349 [TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis in children. Our experience]. López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048 [TBL] [Abstract][Full Text] [Related]
10. [Managing children with neurofibromatosis type 1: what should we look for?]. Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435 [TBL] [Abstract][Full Text] [Related]
11. Images of Lisch nodules across the spectrum. Ragge NK; Falk RE; Cohen WE; Murphree AL Eye (Lond); 1993; 7 ( Pt 1)():95-101. PubMed ID: 8325432 [TBL] [Abstract][Full Text] [Related]
12. Ophthalmological manifestations in segmental neurofibromatosis type 1. Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488 [TBL] [Abstract][Full Text] [Related]
13. Neurological complications involving the central nervous system in neurofibromatosis type 1. Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic outcome in children with multiple café au lait spots. Korf BR Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418 [TBL] [Abstract][Full Text] [Related]
16. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases]. Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P; Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577 [TBL] [Abstract][Full Text] [Related]